Learn more about whether Open Text Corporation or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...

Despite some notable successes, including US approval in January of a nonopioid painkiller by Boston biotech Vertex ... president of Fairway Consulting Group, an executive search firm that ...

A panel of CDC advisers, who had originally been set to meet in February, will discuss the current measles outbreak as well ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...

The sponsorship offers range from $75,000 to $200,000, with the promise of logo and branding opportunities ... of Trump’s first-term USDA. Capitol Consulting Group LLC (Dc): Ferox Strategies ...

LAW FIRM PRESSURE CAMPAIGN HITS CONGRESS: President Donald Trump’s retribution tour against Big Law has arrived on Capitol Hill, Dasha Burns, Daniel and I report. An email circulated by a high ...